Weiyu Shen

1.9k total citations
54 papers, 1.2k citations indexed

About

Weiyu Shen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Weiyu Shen has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 18 papers in Oncology. Recurrent topics in Weiyu Shen's work include Lung Cancer Diagnosis and Treatment (12 papers), Cancer-related molecular mechanisms research (9 papers) and Esophageal Cancer Research and Treatment (8 papers). Weiyu Shen is often cited by papers focused on Lung Cancer Diagnosis and Treatment (12 papers), Cancer-related molecular mechanisms research (9 papers) and Esophageal Cancer Research and Treatment (8 papers). Weiyu Shen collaborates with scholars based in China, United States and Japan. Weiyu Shen's co-authors include Jinxian He, Hui Tian, Lee Jia, Shuai Fang, Jinchang Pan, Xiaodan Meng, Zhaohui Gong, Chengwei Zhou, Xin Jin and Haihua Tian and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Advanced Functional Materials.

In The Last Decade

Weiyu Shen

51 papers receiving 1.2k citations

Peers

Weiyu Shen
Judong Luo China
Yuanjie Niu China
Kai Zhu China
En‐Chi Hsu United States
Teresa Bernadette Steinbichler Austria
Xinjian Fang China
Yi Jin China
Carolina Soekmadji Australia
Tong Lu China
Judong Luo China
Weiyu Shen
Citations per year, relative to Weiyu Shen Weiyu Shen (= 1×) peers Judong Luo

Countries citing papers authored by Weiyu Shen

Since Specialization
Citations

This map shows the geographic impact of Weiyu Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyu Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyu Shen more than expected).

Fields of papers citing papers by Weiyu Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiyu Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyu Shen. The network helps show where Weiyu Shen may publish in the future.

Co-authorship network of co-authors of Weiyu Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Weiyu Shen. A scholar is included among the top collaborators of Weiyu Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyu Shen. Weiyu Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Weiyu, et al.. (2024). CDK7 as a biomarker to predict response to etoposide and carboplatin treatment in limited-stage small cell lung cancer with surgical resection.. Journal of Clinical Oncology. 42(16_suppl). e20104–e20104. 1 indexed citations
2.
He, Jinxian, Gaofeng Liang, Weiyu Shen, et al.. (2024). Two versus three to four cycles of neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma in real-world practice. Journal of Thoracic Disease. 16(10). 6999–7015. 2 indexed citations
3.
Xi, Yong, Jing Zeng, Yundong Zhou, et al.. (2024). Prognostic value and potential biological function of PMSD11 in lung adenocarcinoma. Journal of Thoracic Disease. 16(11). 7819–7835.
4.
Shen, Weiyu, Zhengxia Wang, Jingjing Wu, et al.. (2024). IFN-γ decreases PD-1 in T lymphocytes from convalescent COVID-19 patients via the AKT/GSK3β signaling pathway. Scientific Reports. 14(1). 5038–5038. 2 indexed citations
5.
Wang, Lijie, Jinxian He, Liang Zhang, et al.. (2024). Use of a novel claw-suture technique for localization of solitary pulmonary nodules: retrospective study and experience from one center. Journal of Thoracic Disease. 16(12). 8699–8708. 1 indexed citations
6.
7.
Xi, Yong, et al.. (2023). Amplifying “eat me signal” by immunogenic cell death for potentiating cancer immunotherapy. Immunological Reviews. 321(1). 94–114. 62 indexed citations
8.
Shen, Yaxing, et al.. (2023). Exosome-mediated metabolic reprogramming: Implications in esophageal carcinoma progression and tumor microenvironment remodeling. Cytokine & Growth Factor Reviews. 73. 78–92. 18 indexed citations
9.
Zhu, Keyun, Baichuan Wang, Yue Yu, et al.. (2023). CAVIN2/SDPR Functioned as a Tumor Suppressor in Lung Adenocarcinoma from Systematic Analysis of Caveolae-Related Genes and Experimental Validation. Journal of Cancer. 14(11). 2001–2014. 6 indexed citations
10.
11.
Chen, Tian, Xiaoyu Xu, Gaofeng Liang, et al.. (2022). Inflammation‐based prognostic scoring system for predicting the prognosis of advanced small cell lung cancer patients receiving anlotinib monotherapy. Journal of Clinical Laboratory Analysis. 36(12). e24772–e24772. 6 indexed citations
12.
Shen, Yaxing, Jingtao Zhang, Lijie Wang, et al.. (2022). CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p. Molecular Cancer. 21(1). 145–145. 104 indexed citations
13.
14.
Yu, Chaoqun, et al.. (2020). Circ_0074027 Contributes to Non-Small Cell Lung Cancer Progression by Upregulating CUL4B Expression Through miR-335-5p. Cancer Biotherapy and Radiopharmaceuticals. 37(2). 73–83. 18 indexed citations
15.
Xi, Yong, Weiyu Shen, Lijie Wang, & Chaoqun Yu. (2020). An esophagectomy Surgical Apgar Score (eSAS)-based nomogram for predicting major morbidity in patients with esophageal carcinoma. Translational Cancer Research. 9(3). 1732–1741. 10 indexed citations
16.
Li, Yumei, Yu Zhou, Bifei Li, et al.. (2020). WDR74 modulates melanoma tumorigenesis and metastasis through the RPL5–MDM2–p53 pathway. Oncogene. 39(13). 2741–2755. 20 indexed citations
17.
Pan, Jinchang, Chengwei Zhou, Xiaodong Zhao, et al.. (2018). A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer. Scientific Reports. 8(1). 16699–16699. 85 indexed citations
18.
Shen, Weiyu, et al.. (2018). A nomogram for predicting lymph node metastasis in surgically resected T1 esophageal squamous cell carcinoma. Journal of Thoracic Disease. 10(7). 4178–4185. 21 indexed citations
19.
Gao, Yu, Biyu Jin, Weiyu Shen, et al.. (2015). China and the United States—Global partners, competitors and collaborators in nanotechnology development. Nanomedicine Nanotechnology Biology and Medicine. 12(1). 13–19. 23 indexed citations
20.
Xie, Jingjing, Jichuang Wang, Hongning Chen, et al.. (2015). Multivalent Conjugation of Antibody to Dendrimers for the Enhanced Capture and Regulation on Colon Cancer Cells. Scientific Reports. 5(1). 9445–9445. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judong Luo Breakdown of academic impact, for papers by Yuanjie Niu Breakdown of academic impact, for papers by Kai Zhu Breakdown of academic impact, for papers by En‐Chi Hsu Breakdown of academic impact, for papers by Teresa Bernadette Steinbichler Breakdown of academic impact, for papers by Xinjian Fang Breakdown of academic impact, for papers by Yi Jin Breakdown of academic impact, for papers by Carolina Soekmadji Breakdown of academic impact, for papers by Tong Lu
Rankless by CCL
2026